stockrowAMNEAL PHARMACEUTICALS, INC. (AMRX) vs Lantheus Holdings, Inc. (LNTH)
- AMNEAL PHARMACEUTICALS, INC. AMRX 19.41 −2.71%
- Lantheus Holdings, Inc. LNTH 100.76 −0.38%
AMNEAL PHARMACEUTICALS, INC. and Lantheus Holdings, Inc. are both Drug Manufacturers Specialty & Generic companies. AMNEAL PHARMACEUTICALS, INC. and Lantheus Holdings, Inc. are of similar size ($6.8B and $6.6B). Lantheus Holdings, Inc. trades at the lower P/E: 24.3× against 36.9×. AMNEAL PHARMACEUTICALS, INC. grew revenue faster over the last twelve months: 8.88% against 2.38%. Lantheus Holdings, Inc. has the higher net margin (17.3% vs 4.17%) and the higher return on invested capital (14.6% vs 8.45%). Across the 21 metrics below, Lantheus Holdings, Inc. leads on 16 and AMNEAL PHARMACEUTICALS, INC. on 5.
Valuation
Profitability
| Metric | AMRX | LNTH | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 40.24% | 61.26% | 53.51% |
| Operating margin | 14.99% | 18.62% | 0.00% |
| Net margin | 4.17% | 17.28% | (2.45%) |
| Free cash flow margin | (1.89%) | 26.21% | 0.00% |
| Return on equity | (53,107.17%) | 21.81% | (0.80%) |
| Return on assets | 3.01% | 11.41% | (1.67%) |
| Return on invested capital | 8.45% | 14.62% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack